Literature DB >> 27698858

Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.

Therese Högfeldt1, Crystal Jaing2, Kevin Mc Loughlin3, James Thissen2, Shea Gardner3, Abeer A Bahnassy4, Baback Gharizadeh5, Joachim Lundahl6, Anders Österborg1, Anna Porwit1, Abdel-Rahman N Zekri7, Hussein M Khaled8, Håkan Mellstedt1, Ali Moshfegh1.   

Abstract

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin's lymphoma (NHL) in adults, accounts for approximately 30-40% of newly diagnosed lymphomas worldwide. Environmental factors, such as viruses and bacteria, may contribute to cancer development through chronic inflammation and the integration of oncogenes, and have previously been indicated in cervical cancer, hepatocellular carcinoma, gastric cancer and lymphoproliferative disorders. In the present study, the presence of microbial agents was analyzed in the lymphoma tissue of patients with activated B-cell like (ABC) DLBCL. The present study compared two groups of patients from geographically varied regions that possess a difference in the prevalence of viral and other microbial agents. The patient populations were from Sweden (a low endemic infectious disease region) and Egypt (a high endemic infectious disease region). A differential expression of several viruses in lymphoma tissues was noted when comparing Swedish and Egyptian patients. JC polyomavirus (JCV) was detected in Swedish and Egyptian patients and, uniquely, the complete hepatitis B virus (HBV) genome was detected only in Egyptian lymphoma patients. None of these viruses were detected in control lymph tissues from Sweden or Egypt. In total, 38% of the Egyptian patients were found to have HBV surface antigens (HBsAgs) in their serum; however, HBsAgs were not found in any of the Swedish patients. The percentage of serum HBsAgs in Egyptian patients with ABC DLBCL was significantly increased compared with the general Egyptian population (P<0.05). The present study may support a notion that viral agents, including JCV and HBV, may be involved in the tumorigenesis of DLBCL in regions of high infectious disease.

Entities:  

Keywords:  gene array; hepatitis B virus; lymphoma and Hodgkin disease; molecular genetics; virus

Year:  2016        PMID: 27698858      PMCID: PMC5038175          DOI: 10.3892/ol.2016.5012

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  62 in total

1.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

Review 2.  Viruses and lymphoma/leukaemia.

Authors:  Ruth F Jarrett
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

3.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.

Authors:  Joseph G Victoria; Chunlin Wang; Morris S Jones; Crystal Jaing; Kevin McLoughlin; Shea Gardner; Eric L Delwart
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

5.  Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.

Authors:  R M Weber-Nordt; C Egen; J Wehinger; W Ludwig; V Gouilleux-Gruart; R Mertelsmann; J Finke
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

6.  Gene expression analysis using long-term preserved formalin-fixed and paraffin-embedded tissue of non-small cell lung cancer.

Authors:  Therese A S Jacobson; Joachim Lundahl; Håkan Mellstedt; Ali Moshfegh
Journal:  Int J Oncol       Date:  2011-02-08       Impact factor: 5.650

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

Review 8.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

Review 9.  Human polyomaviruses in disease and cancer.

Authors:  Tina Dalianis; Hans H Hirsch
Journal:  Virology       Date:  2013-01-26       Impact factor: 3.616

10.  Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders.

Authors:  Vahap Okan; Mehmet Yilmaz; Aysen Bayram; Cem Kis; Sami Cifci; Hakan Buyukhatipoglu; Mustafa Pehlivan
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

View more
  2 in total

1.  Associations of Viral Seroreactivity with AIDS-Related Non-Hodgkin Lymphoma.

Authors:  Minkyo Song; Bryan A Bassig; Noemi Bender; James J Goedert; Cheryl A Winkler; Nicole Brenner; Tim Waterboer; Charles S Rabkin
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-02       Impact factor: 2.205

2.  Axiom Microbiome Array, the next generation microarray for high-throughput pathogen and microbiome analysis.

Authors:  James B Thissen; Nicholas A Be; Kevin McLoughlin; Shea Gardner; Paul G Rack; Michael H Shapero; Raymond R R Rowland; Tom Slezak; Crystal J Jaing
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.